EZH2 and pancreatic insulinoma: A previous study reported dysregulation of epigenetic factors including genomic amplification of EZH2 and overexpression of EZH2 promoted CCND1-induced proliferation of insulinoma cells in human (Wang et al., 2017), whereas declined functions of these factors with aging were previously reported in mice (Chen et al., 2009).